This study aimed to investigate the effect of yeast cell walls (YCW) on the growth performance, visceral lesions, intestinal integrity, enterotoxicit

The present study aimed to investigate the effect of probiotic Lactobacilli addition on Listeria monocytogenes load, inflammatory reaction, and virulence properties in broilers from 1 to 14 D of age. A total of 480 broiler chicks were randomly allocated to 4 treatments of 6 replicates each. All birds were infected with L. monocytogenes on the first day and supplemented an equal amount mixture of Lactobacillus acidophilus and Lactobacillus plantarum at doses of 0 (control), 106, 108, 1010 cfu/kg of diet. The results showed that on 7 and 14 D after administration, Lactobacilli addition at the 3 doses decreased (P < 0.05) L. monocytogenes loads in the cecum, skin, liver, and spleen by 0.065 to 0.933 log10 cfu, and the pathogen linearly reduced (P ≤ 0.015) with the increasing doses of probiotics in the skin. Serum cytokines including IL-1β, IL-6, tumor necrosis factor-α, and interferon-γ in probiotics treatments were decreased (P < 0.05) by 25.4 to 51.1%. Transcriptional levels of genes related to anti-inflammatory reactions including IL-10, hypoxia inducible factor 1 alpha (HIF1A), prostaglandin E receptor 2, and prostaglandin-endoperoxide synthase 2 in the intestinal mucosa were upregulated (P < 0.05) in Lactobacilli treatments, and linear and quadratic responses (P ≤ 0.019) were found on HIF1A. Furthermore, the probiotics attenuated (P < 0.05) listerial adhesion, pore-forming, and invasion properties by downregulating autolysin Ami, listeriolysin O, internalin A and B, and a linear (P = 0.006) dose response of probiotics was exhibited on flagellin. The findings indicate that dietary coadministration of L. acidophilus and L. plantarum can attenuate L. monocytogenes infection by depressing its intestinal inoculation, translocation, inflammatory reaction, and virulence property in broilers and suggest that the probiotics can be an alternative against listerial infection in broilers.

Astaxanthin (Ax) and lutein are important fat-soluble pigments and essential nutrients for human and animal health. Haematococcus pluvialis microalga and Phaffia rhodozyma yeast are ideal species for commercial Ax production. Marigold flowers are a main source of commercial lutein. Dynamics of dietary Ax and lutein in the gastrointestinal tract are similar to lipids, but their activities are tremendously challenged by many physiological and dietary factors; few data are available about these in poultry. Dietary Ax and lutein have insignificant effects on egg production and egg physical properties, but have pronounced effects on yolk color, nutrition, and functionality. The two pigments can also enhance antioxidative capacity and immune function of laying hens. A few studies have shown that Ax and lutein can improve fertilization and hatchability of laying hens. Considering the pigmentation and health benefits of Ax and lutein from hen feed to human food, the commercial availability, chicken yolk improvement, and immune function of Ax and lutein are the focuses of this review. The potential roles of carotenoids in the cytokine storm and gut microbiota are also briefly presented. The bioavailability, metabolism, and deposition of Ax and lutein in laying hens are suggested for future research.

Lactic acid bacteria (LAB) and the glutathione (GSH) pathway are protective against aflatoxin, but information on the effect of LAB on aflatoxin metabolism and GSH activity in farm animals is scarce. This study aimed to investigate the effects of LAB and aflatoxin B₁ (AFB₁) on growth performance, aflatoxin metabolism, and GSH pathway activity using 480 male Arbor Acres broiler chickens from d 1 to 35 of age. Diets were arranged in a 2 × 2 factorial design, including AFB₁ at 0 or 40 µg/kg of feed and LAB at 0 or 3 × 10¹⁰ cfu/kg of feed, and the LAB was a mixture of equal amounts of Lactobacillus acidophilus, Lactobacillus plantarum, and Enterococcus faecium. The results showed that there were highly significant (P < 0.01) effects of AFB₁ toxicity, LAB protection, and their interaction on ADFI, ADG, and G:F of broilers during d 1 to 35. Compared with the AFB₁ diet, the LAB diet reduced (P < 0.05) the residues of AFB₁ in the liver, kidney, serum, ileal digesta, and excreta on d 14 by 121.5, 80.6, 43.7, 47.0, and 26.5%, respectively, and on d 35 by 40.6, 60.2, 131.7, 37.9, and 32.9%, respectively, whereas the LAB diet increased (P < 0.05) the contents of aflatoxin M₁, a metabolite of AFB₁, in the liver, kidney, serum, and ileal digesta on d 14 by 98.2, 154.2, 168.6, 19.1, and 34.1%, respectively, and in the kidney and serum on d 35 by 32.6 and 142.2%, respectively. For the activity of the GSH pathway in the liver and duodenal mucosa, there were significant (P ≤ 0.01) effects of LAB and AFB₁ on reduced GSH, glutathione S-transferases (GST), and glutathione reductase (GR) on d 14 and 35; compared with the control diet, the LAB diet increased (P < 0.05) GSH, GST, and GR by a range of 11.6 to 86.1%, and compared with the AFB₁ diet, the LAB diet increased (P < 0.05) GSH, GST, and GR by a range of 24.1 to 146.9%. In the liver, there were interactions (P < 0.05) on GSH and GST on d 14 and on GSH on d 35; in the mucosa, interactions were significant (P ≤ 0.01) on GSH and GR on d 14 and on GST on d 35. It can be concluded that LAB is effective in the detoxification of AFB₁ by modulating toxin metabolism and activating the GSH pathway in animals.